Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of FBRX will decline by -19.02% over the next 2 Weeks and hit $29.72 by Thursday, July 23, 2026. In that time frame, FBRX's share price is expected to range between $26.36 and $32.87.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 23, 2026 | 26.36 | 29.72 | 32.87 |
| Jul 22, 2026 | 24.29 | 27.54 | 30.76 |
| Jul 21, 2026 | 26.13 | 29.22 | 32.47 |
| Jul 20, 2026 | 25.39 | 28.67 | 32.08 |
| Jul 17, 2026 | 25.47 | 28.68 | 31.95 |
| Jul 16, 2026 | 26.47 | 29.72 | 32.89 |
| Jul 15, 2026 | 24.41 | 27.54 | 30.78 |
| Jul 14, 2026 | 25.73 | 29.22 | 32.44 |
| Jul 13, 2026 | 25.39 | 28.67 | 31.88 |
| Jul 10, 2026 | 25.56 | 28.68 | 31.75 |
FBRX shares rose +19.56% in Friday, July 10, 2026's trading session, rising from a previous close of $36.70 to move at $43.88. The stock demonstrated notable intraday movement (see FBRX's key stats for a full breakdown), fluctuating between $37.50 and $45.36, a +20.96% trading range. While recent weeks have seen some volatility, FBRX has managed to secure a +134.53% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 4.83M shares changing hands, 4.24M more than the previous session. This amounted to $211.97M in total market activity.
Will FBRX Continue Its Downward Trend?
According to analyst ratings and projections for FBRX, Forte Biosciences, Inc. shares are anticipated to decrease by -33.50%, potentially reaching $32.87 per share by July 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for FBRX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the FBRX stock forecast, now is not the best time to buy FBRX stock because its current trading price is +47.64% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on FBRX covering social and institutional perspectives.
FBRX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into FBRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 80.33% to 90.65%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 65.17%, suggests strong medium-term momentum. However, the 100-day RSI, at 59.28%, maintains a neutral outlook for the long term. Insights into FBRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Forte Biosciences Short-Term Forecasts
FBRX Forecast For Next 5 Days
Our algorithm anticipates Forte Biosciences (FBRX) stock could hit $30.86 by Jul 17, 2026. This represents a -29.67% rise from today's price, following a +2.53% change over the past five days.
FBRX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Forte Biosciences, Inc. (FBRX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $29.49, which would mean a -32.79% decrease from the current price of $43.88. Projections for this period range from a high of $38.06 to a low of $21.69.
FBRX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Forte Biosciences's price over the next three months point to a drop. FBRX stock is expected to peak at $35.03 on Aug 04, 2026 after potentially dipping to $25.84 on Jul 10, 2026. On average, FBRX is likely to trade around $30.46 in the coming 90 days.
Forte Biosciences Stock Forecast 2025
Based on our predictive models, Forte Biosciences (FBRX) is expected to trade between $20.05 and $35.16 throughout 2026. This would result in an average price of $29.91, potentially offering investors a -31.84% return from current levels.
Forte Biosciences, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Forte Biosciences, Inc. (FBRX) is positioned to show a strong performance in July 2026. The price is predicted to move between $25.84 and $34.60, settling at an average of $30.22. This could translate to a -31.13% loss.
August 2026
Based on current market signals, Forte Biosciences, Inc. is projected to trend august 2026. We forecast a trading range from $26.67 to $35.03, with a likely average price of $31.15. Investors could expect a potential return of -29.01%.
September 2026
Our predictive algorithms indicate Forte Biosciences, Inc. stock may see a shift in September 2026. The expected range spans $26.14–$33.91, with an average target of $30.26. This represents a cautious outlook and a possible loss of -31.04%.
October 2026
Analyzing established trends, Forte Biosciences, Inc. looks set to move in October 2026. Projections place the stock between $21.04 and $32.78, averaging around $28.89. This suggests a -34.16% loss from current levels.
November 2026
Market indicators suggest Forte Biosciences, Inc. could experience notable changes during November 2026. Prices could fluctuate within $20.05 to $32.67, with a midpoint forecast of $28.93. The stock might deliver a -34.07% loss.
December 2026
Forecasting for December 2026, models estimate that Forte Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $25.41 and $35.16, averaging $30.09. This signals a cautious trajectory with potential returns around -31.43%.
January 2027
According to our latest forecast models, Forte Biosciences, Inc. (FBRX) is positioned to show a strong performance in January 2027. The price is predicted to move between $27.38 and $34.73, settling at an average of $31.04. This could translate to a -29.26% loss.
February 2027
Based on current market signals, Forte Biosciences, Inc. is projected to trend february 2027. We forecast a trading range from $26.58 to $34.07, with a likely average price of $30.41. Investors could expect a potential return of -30.70%.
March 2027
Our predictive algorithms indicate Forte Biosciences, Inc. stock may see a shift in March 2027. The expected range spans $25.16–$32.82, with an average target of $29.20. This represents a cautious outlook and a possible loss of -33.45%.
April 2027
Analyzing established trends, Forte Biosciences, Inc. looks set to move in April 2027. Projections place the stock between $25.30 and $33.25, averaging around $29.34. This suggests a -33.14% loss from current levels.
May 2027
Market indicators suggest Forte Biosciences, Inc. could experience notable changes during May 2027. Prices could fluctuate within $26.07 to $34.85, with a midpoint forecast of $30.28. The stock might deliver a -30.99% loss.
June 2027
Forecasting for June 2027, models estimate that Forte Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $26.86 and $34.61, averaging $31.09. This signals a cautious trajectory with potential returns around -29.15%.
July 2027
According to our latest forecast models, Forte Biosciences, Inc. (FBRX) is positioned to show a strong performance in July 2027. The price is predicted to move between $27.39 and $33.74, settling at an average of $30.47. This could translate to a -30.56% loss.
FBRX's history of dividends and stock splits also plays a role in long-term investor confidence.

